Keep up with tech in 5 minutes

Get the free daily email with summaries of the most interesting stories in startups 🚀, tech 📱, and programming 💻!

Join 1,600,000 readers for one daily email
Google reveals Nano Banana 2 AI image model, coming to Gemini today (3 minute read)

Google reveals Nano Banana 2 AI image model, coming to Gemini today (3 minute read)

Nano Banana 2, also known as Gemini 3.1 Flash Image, delivers results similar to Nano Banana Pro but with the speed of the non-pro Flash variant. The new image generator has more advanced world knowledge, which gives it the necessary information to render objects with greater fidelity and create more accurate infographics. Nano Banana 2 will replace both the standard and Pro variants of Nano Banana across the Gemini app, Search, AI Studio, Vertex AI, and Flow. Example images generated with the model are available in the article.
Nano Banana 2 (5 minute read)
Feb 27 | AI

Nano Banana 2 (5 minute read)

Google's Nano Banana 2 (Gemini 3.1 Flash Image) combines the advanced reasoning and image quality of Nano Banana Pro with significantly faster generation speeds.
Block Announces Layoffs of 4,000 People, Over 40% Cut (7 minute read)
Feb 27 | Dev

Block Announces Layoffs of 4,000 People, Over 40% Cut (7 minute read)

Block is laying off over 4,000 employees, nearly 40% of its total workforce. Jack Dorsey, the CEO, stated the drastic cut was due to AI fundamentally changing how the company builds and operates. Block's stock soared by nearly 25% in after-hours trading following the announcement.
10 Charts That Capture How the World Is Changing (11 minute read)
Feb 27 | Founders

10 Charts That Capture How the World Is Changing (11 minute read)

This article presents ten charts that illustrate major global shifts, covering topics like AI adoption, healthcare employment, and venture capital secondary markets. AI is still in early stages, with 84% of people yet to use AI products, while healthcare is creating significant job growth. Moreover, secondaries are emerging as a vital liquidity option in venture capital, and Retatrutide shows promise as a groundbreaking drug in peptide therapeutics.

More Stories